Welcome to our dedicated page for Scotts Miracle Gr SEC filings (Ticker: SMG), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Scotts Miracle-Gro Company (NYSE: SMG) files a range of documents with the U.S. Securities and Exchange Commission that provide detailed insight into its operations, governance and financial condition. As an Ohio‑incorporated issuer with common shares listed on the New York Stock Exchange, ScottsMiracle-Gro uses periodic reports and current reports to describe its branded consumer lawn and garden business, indoor and hydroponic growing operations and related financing arrangements.
On this page, you can review core filings such as the annual report on Form 10‑K and quarterly reports on Form 10‑Q, which include segment information for U.S. Consumer, Hawthorne and Other, along with discussions of risk factors, liquidity, capital resources and segment performance. These filings also elaborate on topics referenced in company news releases, such as gross margin trends, leverage, free cash flow and the role of credit facilities and receivables programs in the capital structure.
Current reports on Form 8‑K provide more targeted updates. Recent 8‑K filings describe a Seventh Amended and Restated Credit Agreement establishing senior secured loan facilities, amendments to a master receivables purchase agreement, results of operations for specific quarters and changes to the board of directors and equity award documentation. These filings outline key terms such as leverage and interest coverage covenants, security packages and the use of proceeds for working capital and general corporate purposes.
Definitive proxy statements on Schedule 14A offer detail on corporate governance and executive compensation. ScottsMiracle-Gro’s proxy materials cover board composition, committee responsibilities, director independence, say‑on‑pay proposals, long‑term incentive plan terms, stock ownership guidelines and severance and change‑in‑control arrangements.
This filings page combines real‑time access to new EDGAR submissions with AI‑generated summaries that explain the structure and implications of each document. Users can quickly identify items such as 10‑K and 10‑Q reports, 8‑K current reports, proxy statements and exhibits related to credit agreements or incentive plans, and use the summaries to focus on the sections most relevant to their analysis of SMG.
SCOTTS MIRACLE-GRO CO (SMG) reporting person Mark J. Scheiwer, identified as EVP, CFO & CAO, reported a transaction on 09/30/2025. The filing shows a non-derivative acquisition recorded at a price of $48.66 and indicates total beneficial ownership following the transaction of 10,136.2655 common shares. The report also discloses 433.874 shares held indirectly through a 401(k) plan. The Form 4 is signed by an attorney-in-fact on behalf of the reporting person.
Christopher J. Hagedorn, EVP & Chief of Staff of The Scotts Miracle-Gro Company (SMG), reported a transaction on 09/05/2025 in the company’s common shares. The Form 4 records a transaction code J with an entry showing 2.6532 (listed under the V column) and a price of $62.5085. Following the reported transaction, the form lists 54,062.07 shares beneficially owned. The filing was signed on behalf of Mr. Hagedorn by an attorney-in-fact on 09/30/2025. No additional explanatory remarks are provided in the form.
Nathan Eric Baxter, President and COO and a director of Scotts Miracle-Gro Company (SMG), filed a Form 4 reporting transactions dated 09/05/2025. The filing shows a non-derivative acquisition with codes listed as J and V, a quantity shown as 19.5915 A at a price of $62.5085. Following the reported transactions the filing shows 50,728.1148 (listed with a “D” in the form) as the amount of securities beneficially owned, and separately discloses 36,993 held indirectly through Hagedorn Partnership, L.P. The form includes an explanatory note that the reporting person may be deemed to beneficially own Partnership-held shares under Rule 16a-1(a)(1). The Form 4 is signed by an attorney-in-fact on 09/30/2025.
The Scotts Miracle-Gro Company (SMG) Form 144 notifies the market of a proposed sale of 11,297 common shares, with an aggregate market value of $681,302.71, intended for sale on the NYSE on or about 09/10/2025. The filing identifies the broker as Merrill and reports total shares outstanding of 57,738,577. The securities to be sold were acquired through restricted stock vesting on various dates between 2019 and 2023 from Scotts Miracle-Gro. The filer reports no securities sold in the past three months and certifies no undisclosed material adverse information.
The Scotts Miracle-Gro Company (SMG) director Austin Scott Miller reported an acquisition of 15 common-share equivalents related to dividend equivalent rights on restricted/share units. The transaction date was 09/05/2025 and the Form 4 was signed on 09/09/2025 by an attorney-in-fact. The filing shows 15 shares acquired at an economic value tied to $63.04 each, and 15 shares beneficially owned following the transaction. The filing clarifies these dividend equivalent rights accrue with DSUs/RSUs and are each economically equivalent to one common share. No other transactions, dispositions, or pledges are disclosed in this filing.
The Scotts Miracle-Gro Company (SMG) director Nick Miaritis reported an acquisition of 32 common shares on 09/05/2025. The shares were issued as dividend equivalent rights tied to DSU/RSU grants and were recorded at a price of $63.04 per share. After this transaction, Mr. Miaritis beneficially owned 93 shares. The filing was signed on behalf of the reporting person by an attorney-in-fact on 09/09/2025. The form notes that dividend equivalents accrue with DSUs/RSUs and are economically equivalent to common shares.
Roberto Candelino, a director of The Scotts Miracle-Gro Company (SMG), reported a small acquisition of company shares. On 09/05/2025 he received 36 common shares as dividend equivalent rights related to DSU/RSU grants at an economic value of $63.04 per share. The filing shows he beneficially owned 108 common shares following the transaction, held directly.
The Form 4 was signed on behalf of Mr. Candelino by an attorney-in-fact on 09/09/2025. The filing explains that dividend equivalent rights track DSU/RSU vesting and are each economically equivalent to one common share.
James Hagedorn, Chairman & CEO of The Scotts Miracle-Gro Company (SMG), reported acquiring 2,297.999 units of phantom stock on 09/05/2025. Each phantom share represents the right to one common share or its cash value. The reported acquisition was at a per-unit reference price of $63.341 and increases Hagedorn's beneficial ownership to 224,273.963 common shares. The phantom shares are payable in cash following termination of employment, and the reporting person may transfer the phantom stock into an alternative investment at any time. The Form 4 was signed by an attorney-in-fact on behalf of Mr. Hagedorn on 09/09/2025.
Edith Aviles, a director of The Scotts Miracle-Gro Company (SMG), reported a Section 16 transaction dated 09/05/2025. The filing shows the acquisition of 104 dividend equivalent rights that are the economic equivalents of common shares, recorded at $63.04 per share. After the reported transaction, Ms. Aviles directly beneficially owned 662 common shares. The filing was signed on behalf of Ms. Aviles by an attorney-in-fact on 09/09/2025 and explains that dividend equivalent rights vest proportionately with the related DSUs/RSUs.
Mark D. Kingdon, a director of The Scotts Miracle-Gro Company (SMG), reported an acquisition of 91 dividend equivalent rights tied to DSU/RSU awards on 09/05/2025. The filing shows each dividend equivalent right is economically equivalent to one common share and the transaction price reported is $63.04 per share. After this reported acquisition, Mr. Kingdon beneficially owns 506 common shares in a direct ownership form. The Form 4 was submitted with a signature by an attorney-in-fact on behalf of the reporting person on 09/09/2025.